value-based care

Interview

The Potentials and Barriers of Precision Medicine in Oncology

06/20/2016

In the mid-1980s, cancer researchers shifted their focus from determining the location of a cancer to identifying the genetic mutations that create it.1 This shift gave birth to a new field of study known as...

In the...

06/20/2016

Journal of Clinical Pathways

Conference Coverage

Perceptions of ICER Reports and Health Technology Assessments in the United States

06/20/2016

JCP Editors

Michael Barry, MD, PhD, clinical director at the National Centre for Pharmaceoeconomics in Dublin, Ireland, initiated the session, “Payers’ use of Independent Reports in Decision Making—Will There Be an ICER Effect,”...

...

06/20/2016

Journal of Clinical Pathways

How Value Frameworks Are Changing US Health Care

06/20/2016

JCP Editors

In “What’s Next for Value-Frameworks in the U.S.?” a key session at ISPOR 2016, Lowell E Schnipper, MD, chair of the American Society of Clinical Oncology (ASCO), began by discussing why ASCO made the decision to...

In...

06/20/2016

Journal of Clinical Pathways

Conference Coverage

2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting

06/20/2016

JCP Editors

Founded in 1995, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is one of the leading organizations promoting the research of health economics and value-based care. Currently, ISPOR is...

...

06/20/2016

Journal of Clinical Pathways

Research in Review

Formula for Optimal Radiosurgery Dose Developed to Guide Brain Metastasis Treatment

06/15/2016

JCP Editors

Researchers from the department of radiation oncology at the VU University Medical Center in Amsterdam, the Netherlands, have proposed a novel formula for the optimization of radiosurgery dose for any given lesion...

...

06/15/2016

Journal of Clinical Pathways

Quality and Value: Measuring and Utilizing Both in Your Practice

06/07/2016

JCP Editors

Anne C Chiang, MD, PhD, Yale School of Medicine (New Haven, CT), spoke first at the “Quality and Value: Measuring and Utilizing Both in Your Practice” session at the 2016 American Society of Clinical Oncology Annual...

Anne C...

06/07/2016

Journal of Clinical Pathways

MACRA Town Hall: Effects on Your Medicare Reimbursement

06/06/2016

JCP Editors

At the “MACRA Town Hall: Effects on your Medicare Reimbursement,” session, Blase Polite, MD, MPP, University of Chicago, Illinois described MACRA using three key adjectives: personal, immediate, and certain. First,...

At the...

06/06/2016

Journal of Clinical Pathways

From the Field

Mock Clinical Pathways: A Method for Exploring the Oncology Clinical Pathway Development Process

05/06/2016

Bruce Feinberg, DO

Monica Lingam, MS

Bing-E Xu, PhD

Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care as well as to make costs and outcomes more predictable, measurable, and accountable. A mock clinical...

...

05/06/2016

Journal of Clinical Pathways

Research in Review

New Clinical Pathways Definition Developed to Help Guide Future Research

04/11/2016

JCP Editors

Using the foundation of past studies, researchers have described the process for developing, refining, and pilot testing a set of criteria for a practical operational definition of clinical pathways in health...

Using...

04/11/2016

Journal of Clinical Pathways

Editor's Page

Value in Health Care: In the Eye of the Beholder

04/08/2016

Winston Wong, PharmD, Editor-in-Chief

Value is defined differently depending on who is defining it. Still, whether value is being defined by the health care provider, the payer, the patient, or industry, the importance of evidence-based treatment...

Value...

04/08/2016

Journal of Clinical Pathways